Investigation of the complement system in clinical practice;Le complément en médecine interne

Annales de Medecine Interne

Volumn 154, Issue 8, 2003, Pages 529-540

  Frémeaux Bacchi, Véronique ^a   Dragon Durey, Marie Agnès ^a   Blouin, Jacques ^a   Mouthon, Luc ^b   Fridman, Wolf Herman ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b AVICENNE HOSPITAL   (France)

Author keywords

Auto immune disease; Complement; Deficiencies; Hemolytic and uremic syndrome; Neisseria meningitidis

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4;

AUTOIMMUNE DISEASE; CLINICAL PRACTICE; COMPLEMENT ACTIVATION; COMPLEMENT DEFICIENCY; COMPLEMENT HEMOLYSIS TEST; COMPLEMENT SYSTEM; DISEASE COURSE; HOST RESISTANCE; HUMAN; IMMUNE COMPLEX DISEASE; INFECTION RESISTANCE; PATHOGENESIS; REVIEW;

ANGIONEUROTIC EDEMA; AUTOIMMUNE DISEASES; COMPLEMENT ACTIVATION; COMPLEMENT C3; COMPLEMENT C4; COMPLEMENT HEMOLYTIC ACTIVITY ASSAY; COMPLEMENT PATHWAY, ALTERNATIVE; COMPLEMENT PATHWAY, CLASSICAL; COMPLEMENT SYSTEM PROTEINS; CRYOGLOBULINEMIA; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEMOLYTIC-UREMIC SYNDROME; HETEROZYGOTE; HOMOZYGOTE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MENINGOCOCCAL INFECTIONS; NEISSERIA MENINGITIDIS; PROPERDIN;

EID: 1642275121     PISSN: 0003410X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. WALPORT MJ: Complement. First of two parts. N Engl J Med, 2001; 344: 1058-66.
2. WALPORT MJ: Complement. Second of two parts. N Engl J Med, 2001; 344: 1140-4.
3. MORGAN BP, WALPORT MJ: Complement deficiency and disease. Immunol Today, 1991; 12: 301-6.
4. WALPORT MJ: Complement and systemic lupus erythematosus. Arthritis Res, 2002; 4: S279-93.
5. PICKERING MC, BOTTO M, TAYLOR PR, LACHMANN PJ, WALPORT MJ: Systemic lupus erythematosus, complement deficiency, and apoptosis. Adv Immunol, 2000; 76: 227-324.
6. BOTTO M, DELL'AGNOLA C, BYGRAVE AE, THOMPSON EM, COOK HT, PETRY F, et al.: Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet, 1998; 19: 56-9.
7. TAYLOR PR, CARUGATI A, FADOK VA, COOK HT, ANDREWS M, CARROLL MC, et al.: A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo. J Exp Med, 2000; 192: 359-66.
8. KAZATCHKINE M, HAUPTMANN G, NYDEGGER U: Techniques du complément. Collection: Techniques en Immunologie. Paris: INSERM, 1985.
9. JOHNSON CA, DENSEN P, HURFORD RK Jr, COLTEN HR, WETSEL RA: Type I human complement C2 deficiency. A 28-base pair gene deletion causes skipping of exon 6 during RNA splicing. J Biol Chem, 1992; 267: 9347-53.
10. CARROLL MC, CAMPBELL RD, BENTLEY DR, PORTER RR: A molecular map of the human major histocompatibility complex class III region linking complement genes C4, C2 and factor B. Nature, 1984; 307: 237-41.
11. BLANCHONG CA, ZHOU B, RUPERT KL, CHUNG EK, JONES KN, SOTOS JF, et al.: Deficiencies of human complement component C4A and C4B and heterozygosity in length variants of RP-C4-CYP21-TNX (RCCX) modules in caucasians. The load of RCCX genetic diversity on major histocompatibility complex-associated disease. J Exp Med, 2000; 191: 2183-96.
12. TAN EM, COHEN AS, FRIES JF, MASI AT, MCSHANE DJ, ROTHFIELD NF, at al.: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum, 1982; 25: 1271-7.
13. FRÉMEAUX-BACCHI V, NOEL LH, SCHIFFERLI JA: No lupus nephrifis in the absence of antiC1q autoantibodies? Nephrol Dial Transplant, 2002; 17: 2041-3.
14. FRÉMEAUX-BACCHI V, WEISS L, DEMOUCHY C, MAY A, PALOMERA S, KAZATCHKINE MD: Hypocomplementaemia of poststreptococcal acute glomerulonephritis is associated with C3 nephritic factor (C3NeF) IgG autoantibody activity. Nephrol Dial Transplant, 1994; 9: 1747-50.
15. SULLIVAN KE: Complement deficiency and autoimmunity. Curr Opin Pediatr, 1998; 10: 600-6.
16. CHRISTIANSEN FT, ZHANG WJ, GRIFFITHS M, MALLAL SA, DAWKINS RL: Major histocompatibility complex (MHC) complement deficiency, ancestral haplotypes and systemic lupus erythematosus (SLE): C4 deficiency explains some but not all of the influence of the MHC. J Rheumatol, 1991; 18: 1350-8.
17. PETRI M, WATSON R, WINKELSTEIN JA, MCLEAN RH: Clinical expression of systemic lupus erythematosus in patients with C4A deficiency. Medicine (Baltimore), 1993; 72: 236-44.
18. HARTUNG K, BAUR MP, COLDEWEY R, FRICKE M, KALDEN JR, LAKOMEK HJ, et al.: Major histocompatibility complex haplotypes and complement C4 alleles in systemic lupus erythematosus. Results of a multicenter study. J Clin Invest, 1992; 90: 1346-51.
19. SULLIVAN KE, KIM NA, GOLDMAN D, PETRI MA: C4A deficiency due to a 2 bp insertion is increased in patients with systemic lupus erythematosus. J Rheumatol, 1999; 26: 2144-7.
20. DRAGON-DUREY MA, ROUGIER N, CLAUVEL JP, CAILLATZUCMAN S, REMY P, GUILLEVIN L, et al.: Lack of evidence of a specific role for C4A gene deficiency in determining disease susceptibility among C4-deficient patients with systemic lupus erythematosus (SLE). Clin Exp Immunol, 2001; 123: 133-9.
21. AGOSTONI A, CICARDI M: Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients. Medicine (Baltimore), 1992; 71: 206-15.
22. FRÉMEAUX-BACCHI V, GUINNEPAIN MT, CACOUB P, DRAGON-DUREY MA, MOUTHON L, BLOUIN J, et al.: Prevalence of monoclonal gammopathy in patients presenting with acquired angioedema type 2. Am J Med, 2002; 113: 194-9.
23. HE S, SIM RB, WHALEY K: Mechanism of action of anti-C1-inhibitor autoantibodies: prevention of the formation of stable C1s-C1-inh complexes. Mol Med, 1998; 4: 119-28.
24. FIJEN CA, KUIJPER EJ, TE BULTE MT, DAHA MR, DANKERT J: Assessment of complement deficiency in patients with meningococcal disease in The Netherlands. Clin Infect Dis, 1999; 28: 98-105.
25. FIJEN CA, VANDEN BOGAARD R, SCHIPPER M, MANNENS M, SCHLESINGER M, NORDIN FG, et al.: Properdin deficiency: molecular basis and disease association. Mol Immunol, 1999; 36: 863-7.
26. WARWICKER P, GOODSHIP JA, GOODSHIP TH: Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med, 1999; 340: 1368-9.
27. ROUGIER N, KAZATCHKINE MD, ROUGIER JP, FRÉMEAUX-BACCHI V, BLOUIN J, DESCHENES G, et al.: Human complement factor H deficiency associated with hemolytic uremic syndrome. J Am Soc Nephrol, 1998; 9: 2318-26.
28. PEREZ-CABALLERO D, GONZALEZ-RUBIO C, GALLARDO ME, VERA M, LOPEZ-TRASCASA M, RODRIGUEZDE CORDOBA S, et al. Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome. Am J Hum Genet, 2001; 68: 478-84.
29. FIGUEROA JE, DENSEN P: Infectious diseases associated with complement deficiencies. Clin Microbiol Rev, 1991; 4: 359-95.
30. JARVA H, MERI S: Paroxysmal nocturnal haemoglobinuria: the disease and a hypothesis for a new treatment. Scand J Immunol, 1999; 49: 119-25.
31. NISHIMURA J, MURAKAMI Y, KINOSHITA T: Paroxysmal nocturnal hemoglobinuria: An acquired genetic disease. Am J Hematol, 1999; 62: 175-82.
32. SUMMERFIELD JA, SUMIYA M, LEVIN M, TURNER MW: Association of mutations in mannose binding protein gene with childhood infection in consecutive hospital series. BMJ, 1997; 314: 1229-32.
33. HIBBERD ML, SUMIYA M, SUMMERFIELD JA, BOOY R, LEVIN M: Association of variants of the gene for mannose-binding lectin with susceptibility to meningococcal disease. Meningococcal Research Group. Lancet, 1999; 353: 1049-53.